BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33851202)

  • 1. Usage of Plasma Presepsin, C-Reactive Protein, Procalcitonin and Proadrenomedullin to Predict Bacteremia in Febril Neutropenia of Pediatric Hematological Malignancy Patients.
    Arıkan K; Karadag-Oncel E; Aytac S; Cetin M; Cengiz AB; Gümrük F; Kara A; Ceyhan M
    Lab Med; 2021 Sep; 52(5):477-484. PubMed ID: 33851202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia.
    Özdemir ZC; Düzenli-Kar Y; Canik A; Küskü-Kiraz Z; Özen H; Bör Ö
    Turk J Pediatr; 2019; 61(3):359-367. PubMed ID: 31916713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies.
    Baraka A; Zakaria M
    Int J Hematol; 2018 Aug; 108(2):184-191. PubMed ID: 29616457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia.
    Cerasi S; Leardini D; Lisanti N; Belotti T; Pierantoni L; Zama D; Lanari M; Prete A; Masetti R
    Sci Rep; 2023 Apr; 13(1):6464. PubMed ID: 37081067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies.
    Ebihara Y; Kobayashi K; Ishida A; Maeda T; Takahashi N; Taji Y; Asou N; Ikebuchi K
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28133789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.
    Koizumi Y; Shimizu K; Shigeta M; Okuno T; Minamiguchi H; Kito K; Hodohara K; Yamagishi Y; Andoh A; Fujiyama Y; Mikamo H
    BMC Infect Dis; 2017 Jan; 17(1):27. PubMed ID: 28056845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
    Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
    PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presepsin and Midregional Proadrenomedullin in Pediatric Oncologic Patients with Febrile Neutropenia.
    Agnello L; Bivona G; Parisi E; Lucido GD; Iacona A; Ciaccio AM; Giglio RV; Ziino O; Ciaccio M
    Lab Med; 2020 Nov; 51(6):585-591. PubMed ID: 32221546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
    von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
    Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders.
    Koh H; Aimoto M; Katayama T; Hashiba M; Sato A; Kuno M; Makuuchi Y; Takakuwa T; Okamura H; Hirose A; Nakamae M; Hino M; Nakamae H
    J Infect Chemother; 2016 Jul; 22(7):466-71. PubMed ID: 27184936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia].
    Fu Y; Jiang H; Li LX; Chen J; Zhang JL; Wang LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1296-300. PubMed ID: 24156453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin versus C-Reactive Protein as a Biomarker for Prediction of Bacterial Infection in Children with Febrile Neutropenia in Acute Leukemia.
    Nahar A; Jamal CY; Refat R; Chowdhury T; Akter S; Karim A; Rahman MA; Yeamin MB; Saha BK; Hossain F; Rabbany MA
    Mymensingh Med J; 2023 Jan; 32(1):76-82. PubMed ID: 36594305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia.
    Urbonas V; Eidukaitė A; Tamulienė I
    Cytokine; 2013 Apr; 62(1):34-7. PubMed ID: 23510625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CRP, PCT, IL-6 and presepsin in early diagnosis of bacterial infectious complications in paediatric haemato-oncological patients.
    Plesko M; Suvada J; Makohusova M; Waczulikova I; Behulova D; Vasilenkova A; Vargova M; Stecova A; Kaiserova E; Kolenova A
    Neoplasma; 2016; 63(5):752-60. PubMed ID: 27468879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of procalcitonin and presepsin in the septic febrile neutropenia in acute leukemia patients.
    Moustafa R; Albouni T; Aziz G
    PLoS One; 2021; 16(7):e0253842. PubMed ID: 34324506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenomedullin--A New Marker in Febrile Neutropenia: Comparison With CRP and Procalcitonin.
    Demirkaya M; Tugcu D; Akcay A; Aydogan G; Akıcı F; Salcioglu Z; Ekmekci H; Sevinir B; Balci Ekmekci O
    Pediatr Hematol Oncol; 2015; 32(7):482-9. PubMed ID: 26271020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COMPARISON AMONG PRESEPSIN, PROCALCITONIN, AND C-REACTIVE PROTEIN IN PREDICTING BLOOD CULTURE POSITIVITY AND PATHOGEN IN SEPSIS PATIENTS.
    Xiao H; Zhang H; Wang G; Wang Y; Tan Z; Sun X; Zhou J; Duan M; Zhi D; Hang C; Zhang G; Li Y; Wu C; Zhang H; Xie M; Li C
    Shock; 2024 Mar; 61(3):387-394. PubMed ID: 37878488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.
    Debiane L; Hachem RY; Al Wohoush I; Shomali W; Bahu RR; Jiang Y; Chaftari AM; Jabbour J; Al Shuaibi M; Hanania A; Pravinkumar SE; Schuetz P; Raad I
    Crit Care Med; 2014 Dec; 42(12):2500-7. PubMed ID: 25083975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of serum endothelial adhesion molecules in pediatric patients with leukemia with febrile neutropenia to predict bacteremia.
    Arıkan K; Karadağ-Oncel E; Aytac S; Cengiz AB; Duygu Cetinkaya F; Kara A; Ceyhan M
    Cytokine; 2021 Dec; 148():155692. PubMed ID: 34500368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of presepsin and procalcitonin for prediction of SeptiFast results in critically ill patients.
    Mihajlovic D; Brkic S; Uvelin A; Draskovic B; Vrsajkov V
    J Crit Care; 2017 Aug; 40():197-201. PubMed ID: 28432884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.